India · Delayed Price · Currency is INR 3B Blackbio Dx Statistics
Total Valuation
3B Blackbio Dx has a market cap or net worth of INR 11.42 billion. The enterprise value is 10.51 billion.
| Market Cap | 11.42B |
| Enterprise Value | 10.51B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Sep 22, 2026 |
Share Statistics
3B Blackbio Dx has 8.58 million shares outstanding. The number of shares has decreased by -0.85% in one year.
| Current Share Class | 8.58M |
| Shares Outstanding | 8.58M |
| Shares Change (YoY) | -0.85% |
| Shares Change (QoQ) | +8.90% |
| Owned by Insiders (%) | 47.61% |
| Owned by Institutions (%) | 3.81% |
| Float | 2.77M |
Valuation Ratios
The trailing PE ratio is 20.41.
| PE Ratio | 20.41 |
| Forward PE | n/a |
| PS Ratio | 7.45 |
| PB Ratio | 3.44 |
| P/TBV Ratio | 3.52 |
| P/FCF Ratio | 42.34 |
| P/OCF Ratio | 21.76 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.07, with an EV/FCF ratio of 38.99.
| EV / Earnings | 18.94 |
| EV / Sales | 6.86 |
| EV / EBITDA | 19.07 |
| EV / EBIT | 21.45 |
| EV / FCF | 38.99 |
Financial Position
The company has a current ratio of 5.27, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.27 |
| Quick Ratio | 4.12 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.12 |
| Interest Coverage | 148.92 |
Financial Efficiency
Return on equity (ROE) is 19.89% and return on invested capital (ROIC) is 15.79%.
| Return on Equity (ROE) | 19.89% |
| Return on Assets (ROA) | 11.70% |
| Return on Invested Capital (ROIC) | 15.79% |
| Return on Capital Employed (ROCE) | 18.47% |
| Weighted Average Cost of Capital (WACC) | 6.90% |
| Revenue Per Employee | 17.81M |
| Profits Per Employee | 6.46M |
| Employee Count | 86 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 2.72 |
Taxes
In the past 12 months, 3B Blackbio Dx has paid 180.62 million in taxes.
| Income Tax | 180.62M |
| Effective Tax Rate | 24.30% |
Stock Price Statistics
The stock price has decreased by -2.30% in the last 52 weeks. The beta is 0.48, so 3B Blackbio Dx's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -2.30% |
| 50-Day Moving Average | 1,435.38 |
| 200-Day Moving Average | 1,342.35 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (20 Days) | 3,162 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, 3B Blackbio Dx had revenue of INR 1.53 billion and earned 555.29 million in profits. Earnings per share was 65.19.
| Revenue | 1.53B |
| Gross Profit | 1.15B |
| Operating Income | 490.11M |
| Pretax Income | 743.26M |
| Net Income | 555.29M |
| EBITDA | 551.47M |
| EBIT | 490.11M |
| Earnings Per Share (EPS) | 65.19 |
Balance Sheet
The company has 1.01 billion in cash and 31.07 million in debt, with a net cash position of 975.13 million or 113.62 per share.
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 31.07M |
| Net Cash | 975.13M |
| Net Cash Per Share | 113.62 |
| Equity (Book Value) | 3.32B |
| Book Value Per Share | 388.37 |
| Working Capital | 1.56B |
Cash Flow
In the last 12 months, operating cash flow was 524.76 million and capital expenditures -255.10 million, giving a free cash flow of 269.66 million.
| Operating Cash Flow | 524.76M |
| Capital Expenditures | -255.10M |
| Depreciation & Amortization | 61.36M |
| Net Borrowing | 3.36M |
| Free Cash Flow | 269.66M |
| FCF Per Share | 31.42 |
Margins
Gross margin is 75.29%, with operating and profit margins of 32.00% and 36.25%.
| Gross Margin | 75.29% |
| Operating Margin | 32.00% |
| Pretax Margin | 48.52% |
| Profit Margin | 36.25% |
| EBITDA Margin | 36.00% |
| EBIT Margin | 32.00% |
| FCF Margin | 19.00% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.38%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.38% |
| Dividend Growth (YoY) | 25.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 7.67% |
| FCF Payout Ratio | 15.91% |
| Buyback Yield | 0.85% |
| Shareholder Yield | 1.23% |
| Earnings Yield | 4.90% |
| FCF Yield | 2.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |